COMMUNIQUÉS West-GlobeNewswire

Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal
24/06/2025
REDMOND, Wash., June 24, 2025 (GLOBE NEWSWIRE) -- Inventprise, a clinical stage vaccine invention company, today announced the publication of a landmark preclinical study in Vaccine Journal (Vol. 54, April 30, 2025, [...]
Hapbee Delivers Breakout Q1 2025: Record Growth, Leaner Operations, and a Clear Path to Scalable Profitability
24/06/2025
Following a 198% sales surge in Q4, Hapbee added 191% revenue growth in Q1 2025 while reducing operating expenses by 62% VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: [...]
Major shareholder notification – BlackRock, Inc.
24/06/2025
GN Store Nord A/S hereby announces that on June 23, 2025, pursuant to Section 38(1) and Section 39(1) of the Danish Capital Markets Act, it received a notification from BlackRock, Inc. stating that on June 20, 2025, [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2025
24/06/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 16 juin au 20 juin 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2025
24/06/2025
Aggregated presentation by day and by market Statement of transactions in own shares from June 16th to June 20th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research
24/06/2025
MILPITAS, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Applied StemCell, a leading provider of advanced stem cell and gene editing technologies since 2008, today announced the release of hiEX™ Research iPSC Exosomes , a [...]
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
24/06/2025
MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging [...]
Lulutox Tea UK (Lulutox Tea Detox) Officially Launches in Ireland, USA, Australia & Canada for Natural Digestive Cleanse
24/06/2025
Lulutox Detox Tea officially launches across Ireland, the USA, UK, Australia and Canada. Formulated with natural herbs like dandelion, fennel, and peppermint to support digestion, detox, and gut health—naturally and [...]
Clariane place avec succès une émission obligataire de 400 millions d’euros
24/06/2025
Communiqué de presse Clariane place avec succès une émission obligataire de 400 millions d’euros Paris, le 24 juin 2025 – Clariane (CLARI.PA – ISIN FR0010386334), annonce aujourd’hui avoir placé avec succès une émission [...]
Clariane has successfully completed a bond issue of 400 million euros
24/06/2025
Press release June 24, 2025 Clariane has successfully completed a bond issue in the amount of 400 million euros Paris, June 24, 2025 – Clariane (CLARI.PA – ISIN FR0010386334), announces today that it has successfully [...]
CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension
24/06/2025
Communiqué de presse CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension Opération portée à plus de 5,7 millions d’euros suite à [...]
CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause
24/06/2025
Press release CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause Transaction raised to over 5.7 million euros following full exercise of the extension [...]
Arcoma AB successfully completes directed share issue of SEK 11.0 million (~ EUR 1 million) (MAR)
24/06/2025
Arcoma AB successfully completes directed share issue of SEK 11.0 million (~ EUR 1 million) NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO AUSTRALIA, BELARUS, [...]
Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation
24/06/2025
Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs and Supports Trinity’s Broader [...]
InnovAge PACE Sponsors Documentary Spotlighting National Crisis in Family Caregiving
24/06/2025
PBS “Caregiving” Documentary, featuring Actor Bradley Cooper, Premieres Tonight DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- InnovAge, the nation’s largest provider of the Program of All-inclusive Care for the Elderly ( [...]
Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics
24/06/2025
Vancouver, Canada, June 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel [...]
OneMedNet Announces Additional $3.7 Million of Funding in Private Placement Transactions and Approximately $11 Million in Reductions in Liabilities
24/06/2025
MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that it has [...]
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome
24/06/2025
ASHBURN, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)
24/06/2025
Good Tolerability and Robust Tumor Uptake were Observed in TNBC Animal Models Auger Emitters Offer the Potential Benefit of Enhanced Cytotoxicity, Safety and Ease-of-Use FLORHAM PARK, N.J., June 24, 2025 (GLOBE NEWSWIRE [...]

Pages